Note: This document contains side effect information about fenofibric acid. Some of the dosage forms listed on this page may not apply to the brand name Fibricor.
More frequent side effects include: thrombophlebitis, abnormal hepatic function tests, and increased serum alanine aminotransferase. See below for a comprehensive list of adverse effects.
Applies to fenofibric acid: oral capsule delayed release, oral tablet
Along with its needed effects, fenofibric acid (the active ingredient contained in Fibricor) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking fenofibric acid:
Some side effects of fenofibric acid may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Applies to fenofibric acid: oral delayed release capsule, oral tablet
The most frequently reported side effects were abnormal liver function tests, AST increased, ALT increased, creatine phosphokinase increased, and rhinitis.
Common (1% to 10%): Back pain, arthralgia, myalgia, pain in extremity
Postmarketing reports: Rhabdomyolysis, muscle spasm
Common (1% to 10%): Abdominal pain, nausea, constipation, diarrhea, dyspepsia
Postmarketing reports: Pancreatitis
Common (1% to 10%): Liver function tests abnormal, ALT increased, AST increased
Postmarketing reports: Hepatitis, cirrhosis
Common (1% to 10%): Respiratory disorder, rhinitis, nasopharyngitis, sinusitis, upper respiratory tract infection
Postmarketing reports: Interstitial lung disease
Common (1% to 10%): Headache, dizziness
Common (1% to 10%): Creatine phosphokinase increased, pain
Postmarketing reports: Asthenia
Postmarketing reports: Anemia, hemoglobin decreased, hematocrit decreased, WBC decreased
Postmarketing reports: Acute renal failure, renal failure
Postmarketing reports: High density lipoprotein cholesterol levels severely depressed
Common (1% to 10%): Urticaria, rash
Postmarketing reports: Photosensitivity reactions
Photosensitivity reactions have been reported days to months after initiation; in some cases, patients had reported a prior photosensitivity reaction to ketoprofen.
Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.
Source: Drugs.com Fibricor